Abbott | ABT - Operating Profit


Abbott reported $2.13B in Operating Profit for its fiscal quarter ending in June of 2026.





Operating Profit Change Date
Abbott USD 2.13B 281M Jun/2026
Agilent USD 444M 45M Jun/2026
AtriCure USD 9.66M 9.14M Jun/2026
Baxter International USD 276M 210M Jun/2026
Becton, Dickinson and Co. USD 752M 125M Jun/2026
Bio-Rad Laboratories USD 72.6M 38.5M Jun/2026
Boston Scientific USD 1.24B 190M Jun/2026
Cooper Companies USD 222M 253M Jun/2026
Danaher USD 1.13B 217M Jun/2026
Dexcom USD 318.3M 63M Jun/2026
Edwards Lifesciences USD 519.5M 4.8M Jun/2026
Globus Medical USD -45.97M 209.97M Jun/2026
Insulet USD 129.7M 7.7M Jun/2026
Integra LifeSciences USD 41.29M 29.82M Jun/2026
Intuitive Surgical USD 977.6M 117.9M Jun/2026
J&J USD 7.48B 860M Jun/2026
Medtronic USD 1.84B 254M Jun/2026
Merit Medical Systems USD 60.4M 16.25M Jun/2026
Pfizer USD 667M 4.32B Jun/2026
Smith & Nephew USD 505M 65M Jun/2026
Solventum Corp USD 181M 96M Jun/2026
Stryker USD 1.79B 687M Jun/2026
Tandem Diabetes Care USD -13.79M 3.64M Jun/2026
Teleflex USD 73.07M 36.04M Jun/2026
Terumo JPY 89.48B 58.03B Jun/2026
Thermo Fisher Scientific USD 2.18B 273M Jun/2026
Zimmer Biomet Holdings USD 344.7M 50.4M Jun/2026